Status: current, Defined. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4783921000168118 | Olamlo HCT 40/5/25 (amlodipine 5 mg + hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet, 30 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4783931000168115 | Olamlo HCT 40/5/25 tablet, 30, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Olamlo HCT 40/5/25 tablet, 30, blister pack | Is a | Olamlo HCT 40/5/25 tablet, 30 | true | Inferred relationship | Some | ||
Olamlo HCT 40/5/25 tablet, 30, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
Olamlo HCT 40/5/25 tablet, 30, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
Olamlo HCT 40/5/25 tablet, 30, blister pack | has TP | Olamlo HCT 40/5/25 | true | Inferred relationship | Some | ||
Olamlo HCT 40/5/25 tablet, 30, blister pack | has TPUU | Olamlo HCT 40/5/25 tablet | true | Inferred relationship | Some | 1277285437 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set